Overall, this study convincingly demonstrated oncogenic roles for JDP2 in T-ALL, as well as a link to MCL1 that may explain why JDP2+ T-ALL patients do poorly. The gene discussed is MCL1; the disease is acute lymphoblastic leukemia.